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Abstract
Terpenes are a class of chemical compounds with carbon and hydrogen atoms in
their structure. They can be classified into several classes according to the quantity
of isoprene units present in its structure. Terpenes can have their structure modi-
fied by the addition of various chemical radicals. When these molecules are modi-
fied by the addition of atoms other than carbon and hydrogen, they become
terpenoids. Terpenes and terpenoids come from the secondary metabolism of sev-
eral plants. They can be found in the leaves, fruits, stem, flowers, and roots. The
concentration of terpenes and terpenoids in these organs can vary according to
several factors such as the season, collection method, and time of the day. Several
biological activities and physiological actions are attributed to terpenes and terpe-
noids. Studies in the literature demonstrate that these molecules have antioxidant,
anticarcinogenic, anti-inflammatory, antinociceptive, antispasmodic, and
antidiabetogenic activities. Additionally, repellent and gastroprotective activity is
reported. Among the most prominent activities of monoterpenes and
monoterpenoids are those on the cardiovascular system. Reports on literature reveal
the potential effect of monoterpenes and monoterpenoids on systemic blood pres-
sure. Studies show that these substances have a hypotensive and bradycardic effect.
In addition, the inotropic activity, both positive and negative, of these compounds
has been reported. Studies also have shown that some monoterpenes and
monoterpenoids also have a vasorelaxing activity on several vascular beds. These
effects are attributed, in many cases to the blocking of ion channels, such as voltage-
gated calcium channels. It can also be observed that monoterpenes and
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monoterpenoids can have their effects modulated by the action of the vascular
endothelium. In addition, it has been shown that the molecular structure and the
presence of chemical groups influence the potency and efficacy of these compounds
on vascular beds. Here, the effect of several monoterpenes and monoterpenoids on
systemic blood pressure and vascular smooth muscle will be reported.
Keywords: terpenes, terpenoids, arterial pressure, pharmacological effect, toxicity,
perspective of therapeutic use, anti-hypertensive
1. Introduction
1.1 Terpenes and terpenoids
Terpenes and terpenoids are names frequently interchangeably used. Most
frequently terpene is defined as a hydrocarbon with one or several isoprene units.
When terpene molecules are modified by the addition of atoms other than carbon
and hydrogen, they are more appropriately named terpenoids [1].
Terpenes and terpenoids come from the secondary metabolism of several plants.
They can be found in the leaves, fruits, stem, flowers, and roots [2]. They can be
classified into several classes according to several criteria: 1—the quantity of iso-
prene units present in its structure, among which we can mention the monoter-
penes, diterpenes, sesquiterpenes, and others; 2—the number of cyclic components
in their molecular structure, according to which we have the acyclic, monocyclic,
and bicyclic monoterpenes [1, 3, 4].
Studies in the literature demonstrate that the natural (present in essential oils—
EO) monoterpenes and monoterpenoids have one or several biological/pharmaco-
logical activities, among which the most frequently reported are antioxidant,
anticarcinogenic, anti-inflammatory, repellent, gastroprotective, antinociceptive,
antispasmodic, and antidiabetogenic activities [4, 5].
Among the most prominent and therapeutically potentially promising activities
of natural monoterpenes and monoterpenoids are those on the cardiovascular sys-
tem [6]. Reports on literature, here reviewed and discussed, reveal their effect on
heart (rate and inotropism), systemic blood pressure (SBP), and blood vessels
(direct (myogenic) and indirect (endothelium mediated)) [7–10].
These effects are frequently attributed to activity on ion channels, such as
voltage-dependent Ca2+ channels (VDCC) [11]. These substances can affect the
contractions mediated by electromechanical excitation-contraction coupling
(EMC; ex.: the KCl-induced contraction) or pharmacomechanical excitation-
contraction coupling (PMC; ex.: the Phenylephrine-induced contraction). In
addition, it has been shown that the molecular structure and the presence of
chemical groups influence the potency (pharmacodynamic potency) and efficacy
(pharmacodynamic efficacy) of these compounds on vascular beds [10]. Here we
will call simply maximum efficacy when, at appropriate concentration, total
blockade of a response is induced (it is: complete blockade of contraction or
Emax = 100%).
Here, we described the effects of monoterpenes and monoterpenoids on SBP and
vascular smooth muscle (VSM). This research was carried out predominantly using
articles present in the Pubmed and Pubchem databases. The search included articles
published between 2000 and 2020. The search included 42 monoterpenes and
monoterpenoids. The words used in the research include “monoterpenes”,
“monoterpenoids” and the name of the compounds associated with “cardiovascu-
lar”, “vasorelaxant”, “hypotension”, “hypotensive”, “antihypertensive”, “vascular
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smooth muscle”, or “toxicity”. For easiness of posterior consultation, we presented
the information related to a substance under a heading, which was the common
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103 M
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Perillyl alcohol Vasorelaxant[10] 277.7  5.46 μMB,
443.3  66.83 μMC




Vasorelaxant 1–2 mMA [27]
Carveol Vasorelaxant 662.1  32.85 μMB;
1333.3  225.20 μMC





Menthol Antihypertensive Diet plus 0.5%
menthol




Vasorelaxant 100–500 mMA [33]
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Ref. LD50 Plant source






Vasorelaxant 1012 – 105 M [34]
Vasorelaxant 300 μg/ml (1.94 mM) [36]
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802.50  13.8 μMC
[9]
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Vasorelaxant 78.80  11.91 μMB;
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Thymol Vasorelaxant 64.40  4.41 μMB;
106.40  11.37 μMC
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Vasorelaxant 323.3  14.0 μMB [11]
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(Table 1). In order to allow some basis for evaluation of the therapeutic potential of
these compounds, we include information on toxicity (LD50 values in mammals;
Table 1).
2. Monoterpenes
Monoterpenes are compounds with two isoprene units in their structure. They
can be subdivided according to the number of cycle components in its structure into
acyclic, monocyclic, and bicyclic [68, 69]. Of the natural monoterpenes studied, we
have not found, in any publications, report of cardiovascular effects for myrcene,
ocimene (acyclic), terpinenes, phellandrenes, terpinolene, thujene (monocyclic)
and, 3-carene, camphene, sabinene (bicyclic), and tricyclene on SBP and VSM.
However, several studies in the literature demonstrate that EO containing these






Ref. LD50 Plant source
Citral Vasorelaxant 110.80 μg/ml
(727.8 μM)B, 99.34 μg/
ml (652.56 μM)C











Hypotensive 10–40 mg/kg, i.v. [55]
Vasorelaxant 106 - 101 M [55]











Vasorelaxant 184 (1.1 mM)B and 185
(1.11 mM)C μg/ml
[58, 59]
Vasorelaxant pD2 = 4.0 [60]








Hypotensive 0.3–10 mg/kg, i.v. [62]
Vasorelaxant 1.09 mMB, 663.2 μg/ml
(4.22 mM)C
[62, 63]








Hypotensive 10–100 mg/kg [64–66]
Vasorelaxant 3.6  104 MC [67]
Ref., Reference. ip, Intraperitoneally. v.o, Orally. i.v., Intravenous.
ARange of doses or concentration employed.
BIC50 for KCl-induced contraction (electromechanical coupling) in presence of endothelium.
CIC50 for phenilephrine-induced contraction (pharmacomechanical coupling) in presence of endothelium.
Table 1.
Monoterpenes and monoterpenoids with hypotensive and vasorelaxant effects.
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2.1 Limonene
Limonene (LM) is one of the most common monoterpenes on nature. Studies
have demonstrated that it has low toxicity and have suggested its promising effect
[13]. The LM had a dose-dependent hypotensive effect, associated with bradycardia
in rats (Table 1). LM is also reported to cause delayed ventricular relaxation and
negative inotropism. It has been suggested that these effects are due to an action of
LM on VDCC [12]. In spontaneously hypertensive rats (SHR) with cerebral ische-
mia, LM attenuated the elevation of the blood pressure of the animals [70].
In rat aorta, the LM promoted a marked vasorelaxing effect when administered
in presence of the contractions induced by a solution with a high concentration of
K+ or phenylephrine (PHE). The IC50 values were dependent on the endothelium
and maximum efficacy was documented for both types of contraction. The potency
in endothelium-intact arteries was greater in EMC than in PMC. LM was also able to
relax the contraction induced by BayK8644, a VDCC activator [71], effect in which
the LM presented the greatest potency, suggesting a possible effect of this mono-
terpene on VDCCs [10].
2.2 Pinene
α- and β-pinene are two isomeric bicyclic monoterpenes [72] which, in awake
rats, induced arterial hypotension and tachycardia. ()-β-pinene was significantly
more effective than (+)-α-pinene. The authors suggested that the exocyclic double
bond of ()-β-pinene contributes more to the pharmacological effect than the
endocyclic double bond of (+)-α-pinene. They explained tachycardia as a reflex
response to the hypotension [14].
2.3 p-cimene
P-cymene is a monocyclic monoterpene that in rat’s aorta showed a reversible
vasorelaxant effect, with maximum efficacy and in a concentration-dependent
manner. This effect, independent of the endothelium, indicated a myogenic effect.
Additionally, the participation of K+ channels in the vasorelaxant effect of
p-cymene has been suggested [16].
3. Monoterpenoids
Monoterpenoids are compounds found in several plant species (Table 1).
Concerning their chemical functions, they can be: alcohols, phenolics,
phenylpropanoids, aldehydes, ketones, ethers, or esters. For the following natural
monoterpenoids, no studies were found that described effect on SBP and VSM:




Citronellol is a low toxicity acyclic monoterpenoid [20]. Regarding hemody-
namic parameters, citronellol (1–20 mg/kg, i.v.) is reported to induce hypotension
associated with tachycardia in non-anesthetized rats [18]. This hypotensive effect
was interpreted to occur probably due to a direct vasorelaxant action of citronellol
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in VSM without the participation of the NO and cyclooxygenase (COX) pathway
[18]. In another study, in anesthetized and awake rats, citronellol (1–20 mg/kg, i.v.)
also had a hypotensive effect, but associated with bradycardia. As a probable cause
of this discrepancy, the chirality of the compound was suggested [19].
In rat mesenteric arteries, citronellol had an endothelium-independent
vasorelaxing effect. On the contraction induced by PHE (IC50  130 μM) and KCl,
the effectiveness reached 100%. This monoterpenoid was able to block the influx of
Ca2+ and contraction induced by caffeine and this finding led the authors to also
suggest that it acts on influx and the mobilization of Ca2+ stores [18, 19].
3.1.2 Geraniol
Geraniol (GER) is an acyclic monoterpenoid with low toxicity (Table 1) [73]. In
diabetic animals, the GER attenuated the cardiac changes caused by diabetes
mellitus (DM). The authors suggested that the mechanism for this effect was the
attenuation of changes caused by DM in contractility and systolic duration by
GER [74].
In the aorta of normoglycemic animals, GER (30–300 μM) had a vasorelaxing
effect on contractions induced by PHE and KCl. This effect was more effective on
EMC, suggesting inhibition of Ca2+ channels in the plasma membrane of smooth
cell. The authors demonstrated that the NO, COX, and K+ channels do not partici-
pate in this vasorelaxant effect. In the aorta of diabetic rats, GER (30–300 μM)
reduced tissue hyperresponsiveness to PHE [21].
3.1.3 Linalool
Linalool (LN) is an acyclic tertiary alcohol. In normotensive animals, LN
(1–20 mg/kg, i.v.) led to hypotension and tachycardia. Hypotension was attenuated
by Nω-Nitro-L-arginine methyl ester (L-NAME) and atropine but not by
indomethacin, thus suggesting that the NO and muscarinic receptor pathways
participate in promoting this effect [14, 23]. In Goldblatt hypertensive animals,
LN (200 mg/kg) caused hypotension, of magnitude similar to nifedipine (NIF),
without altering heart rate (HR) [23]. LN also had a hypotensive effect at a dose of
100 mg/kg in SHR [25].
In the mesenteric bed of normotensive animals, LN showed an endothelium-
independent vasorelaxant effect on PMC and EMC, with maximum efficacy. Addi-
tionally, LN inhibited contractions induced by CaCl2 and caffeine, which led the
authors to suggest that the mechanism of action involves the mobilization of Ca2+
from intracellular stores and the influx of Ca2+ through the plasma membrane. The
direct relaxing effect of LN on VSM has been suggested to be responsible for the
hypotensive effect of this compound. In the aorta of normotensive rats with endo-
thelium, LN (100 μM) had a relaxing effect on PHE-induced contraction [23, 75].
3.1.4 Perillyl alcohol
Perillyl alcohol (POH) is a monocyclic alcohol. It had a reversible vasorelaxing
effect in rat aorta, dependent on concentration and maximum efficacy on the KCl
(IC50 277.7  5.46 μM) and PHE-induced (IC50 443.3  66.83 μM) contractions
(Table 1). Among the contractions inhibited by POH, which also inhibited con-
tractions induced by phorbol dibutyrate (PDB) or by BayK8644, the greatest phar-
macological potency was over the contractions induced by KCl and BayK8644,
which suggested that the mechanism of the relaxing effect of POH was inhibition of
VDCCs. However, other mechanisms have not been ruled out [10]. POH (1–2 mM)
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when incubated overnight prevented KCl-, 5-HT-, and U46619-induced
contractions in coronary arteries [27].
3.1.5 Carveol
Carveol (CV) is a monocyclic alcohol found in the mint EO. In rat aorta, the CV
(10–5000 μM) had a vasorelaxing effect, over contractions induced by PHE (IC50
1333.3  225.20 μM) and KCl (IC50 662.1  32.85 μM), which was reversible and
independent of the vascular endothelium. The CV also inhibited contractions
induced by PDB and BayK8644. Due to the greater potency of CV on contractions
induced by KCl and BayK8644, the mechanism of its relaxing effect was attributed
to a probable inhibitory effect on VDCCs [10].
In the human umbilical artery, the CV (1–5000 μM) reduced the basal tone by
approximately 72% and relaxed contractions induced by 5-HT (IC50 of 175.82 μM)
and KCl (IC50 344.25 μM) [76].
3.1.6 Menthol
Menthol is a monocyclic alcohol. In hypertensive animals, menthol (0.5% die-
tary) attenuated the elevation of vasoconstriction (on PHE- and U46619-induced
contraction), blood pressure, the production of reactive oxygen species (ROS), and
mitochondrial dysfunction. This effect probably occur due to the TRPM8 activation
by menthol and involve the calcium signaling–mediated RhoA/Rho kinase pathway
[29, 30].
Menthol showed cutaneous vasorelaxing activity in individuals in
normotensive or in essential hypertension condition, an activity that has been
suggested to involve the endothelium derived hyperpolarizing factor (EDHF) and
NO [33, 77].
3.1.7 α-Terpineol
α-Terpineol (1–30 mg/kg, i.v.), a monocyclic alcohol, induced a reduction in
SBP and tachycardia. These effects were mitigated by L-NAME and suggested to
involve the NO pathway [34].
In mesenteric arteries, α-terpineol induced an endothelium-dependent
vasorelaxant effect on contractions induced by PHE. The vasorelaxant effect of
α-terpineol was not affected by atropine and indomethacin, but by treatment with
L-NAME and 1H-[1,2,4]oxadiazolo[4,3-a]quinoxal in-1-one (ODQ), suggesting the
involvement of the NO/cGMP pathway [34]. In a cannulated mesenteric bed
contracted by perfusion with KCl, α-terpineol (300 μg/ml (1.94 mM)) increased
(by 93%) the mesenteric flow. The vasorelaxant effect of α-terpineol was abolished
by L-NAME, suggesting the participation of NO in this effect [36].
3.1.8 Terpinen-4-ol
Terpinen-4-ol (4TERP) is a monocyclic alcohol. In hypertensive DOCA-salt and
normotensive animals, uninefrectomized or not, 4TERP (1–10 mg/kg, i.v.) induced
a reduction in SBP and bradycardia, with a peak between 20–30 s after administra-
tion. This effect lasted 1–10 minutes for all doses [7, 37].
In VSM of rats, 4TERP showed vasorelaxing effect, reversible and with maxi-
mum effectiveness, on contractions mediated by EMC (IC50 421.43  23.48 μM)
and PMC (IC50 802.50 13.8 μM). It has been suggested that this effect involves the
NO and COX pathway. 4TERP relaxed, with similar potency, the contractions
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induced by BayK, BaCl2, and K
+, presenting IC50 values of 454.2  28.7,
450.5  71.1, and 421.43  23.48 μM, respectively. This suggest the possible inhib-
itory effect of 4TERP on VDCCs. It has been suggested that 4TERP also acts on
other components of myocytes, such as the IP3 pathway and the sensitivity of
contractile proteins to Ca2+ [9].
In ventricular myocytes isolated from rats, 4TERP (30 μM) promoted a small
increase (10.6  2.6%) of L type Ca2+ currents. Above 300 μM the effect was
reversed; 4TERP reduced the amplitude of these currents (IC50 of
1203  0.224 μM). 4TERP increased the Ca2+ spark frequency at low concentrations
and decreased the amplitude of Ca2+ transients at low and high concentrations [78].
Thus, among the effects of 4TERP on the cardiovascular system, the effect on ion
channels was highlighted as a possible mechanism of action.
3.1.9 Borneol
Borneol is a bicyclic alcohol. In rat aorta, borneol had a vasorelaxing effect on
contraction induced by KCl and PHE. This effect was reduced by L-NAME and
indomethacin, showing the involvement of the NO and COX pathway in its mech-
anism [38]. In another study, in rat aorta, borneol inhibited contraction induced by
CaCl2, BayK8644, and caffeine and the authors suggested probable activities of
this monoterpenoid on VDCCs or intracellular Ca2+ stocks as components of its
mechanism of action [39].
3.2 Phenolics
3.2.1 Carvacrol
In anesthetized rats, carvacrol (100 μg/kg, i.p.) decreased HR, SBP, systolic
and diastolic pressure [42]. In normotensive non-anesthetized rats, carvacrol
(1–20 mg/kg, i.v.), had a hypotensive and bradycardic effect [43].
On aorta of rats, on contractions induced by KCl and PHE, carvacrol
(1–1000 μM) showed a reversible inhibitory effect, with maximum efficacy,
concentration-dependent and not dependent on the endothelium. In addition, car-
vacrol inhibited contractions in a Ca2+-free medium. These data together suggested
the hypothesis that the vasorelaxant mechanism of this monoterpenoid involves
multiple mechanisms: the IP3 pathway, the sensitivity of contractile proteins to
Ca2+, and the blocking of VDCCs [44]. In mesenteric arteries, carvacrol (108 –
3  104 M) had a concentrations-dependent vasorelaxing effect on PHE-,
U46619, and KCl-induced contractions. This effect was endothelium independent
and probably involves VOCCs, receptor operator channels (ROC), and store opera-
tor channels (SOC) channels [43]. Carvacrol also has a vasorelaxing effect on
cerebral parenchymal arteries. In this case, this effect was endothelium-dependent
and promoted through the activation of TRPV3 channels that consequently
activated the low and medium conductance Ca2+-activated K+ channels [79].
3.2.2 Thymol
Thymol is a carvacrol isomer. In aorta of rats, thymol (1–1000 μM) has a
reversible and concentration-dependent vasorelaxant effect (in contractions
induced by KCl and PHE). The experiments to elucidate the mechanism of action
showed results very similar to those of carvacrol and led to similar conclusions: the
involvement of the IP3 pathway, the sensitivity of contractile proteins to Ca
2+, and
the blocking of VDCCs [44].
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Anethole (AN) is a phenylpropanoid with very low toxicity, it has been
suggested to have great therapeutic potential [46].
AN (5–10 mg/kg, i.v.) induced, in a concentration-dependent manner, in con-
scious normotensive rats, hypotension and bradycardia (phase 1), followed by
pressoric and bradycardic response (phase 2) [47]. In animals with nicotine-
induced hypertension associated with immobilization stress, AN (125–250 mg/kg, i.
p.) had an anti-hypertensive effect with efficacy similar to physical exercise and
NIF [45].
Soares et al. [48] reported, in relation to concentration, a biphasic effect of AN
on the aortic artery. Between 106 to 104 M, AN induced an increase in basal tone
and PHE-induced contraction in preparations with endothelium. Between 104 and
103 the Figure 2b [48] shows this contraction vanishes and full relaxation stab-
lishes (maximum efficacy). It was suggested that the activity on VDCC (activation
(106 to 104 M) and inhibition (103 to 102 M)) is the probable mechanism of
this effect [48]. Another study with AN in aortic rings reported only vasorelaxing
effects, with higher potencies (for EMC and PMC, IC50: 50–75 μg/ml (0.34–
0.51 mM))[80]. This discrepancy was not explained.
3.3.2 Estragol
Estragole (ES) is an isomer of AN which, at 5–10 mg/kg, i.v., induced effects on
blood pressure very similar to those of AN (see above) [47, 81]. In the aorta artery
of rats with intact endothelium, the ES also had a similar effect to the AN (pre-
dominantly vasorelaxant), except that the amplification effect of the contraction
was smaller and without statistical significance [48].
3.3.3 Eugenol
Eugenol (EUG) is a phenylpropanoid with a long effect half-life and low toxicity
[82]. EUG is probably the most investigated monoterpenoid with effects on the
cardiovascular system. EUG (1–10 mg/kg, i.v.) caused reduction of SBP and HR, in
dose-dependent manner, in normotensive animals (conscious or anesthetized) and
in hypertensive animals (DOCA-salt model). It was suggested that the hypotensive
effect is due to the direct vasorelaxing activity of the EUG [49, 50].
In blood vessels, EUG has a relaxing, reversible effect, partially dependent on
the endothelium [51, 83]. In rat aorta, with endothelium, this phenylpropanoid
inhibited PHE-induced contraction in normotensive (EUG at 1–100 μM) and
hypertensive animals (EUG at 0.006–6 mM, DOCA-salt model) [48, 75, 84].
The vasorelaxant effect of the EUG was confirmed with flow measurements. In
normotensive animals, EUG induced an increase in flow through the vascular mes-
enteric bed pre-contracted with KCl (IC50 0.31  0.05 mM) or noradrenaline (0.2, 2
or 20 μM) [50, 85].
EUG also has a vasodilatory effect on pressurized cerebral artery of rats (IC50 of
234.2  11.3 μM) or pre-contracted with K+ (IC50 of 323.3  14.0 μM)[11].
The hypotensive and vasorelaxing effect of the EUG is due to multiple mecha-
nisms, the effect of which on ion channels stands out. In VSM cells, the EUG blocks
VDCCs by the channel pore blocking mechanism and by changing the steady state
of channel inactivation [11, 51]. Consistent with this effect, in rat heart muscle, it
was suggested that the negative inotropic effect of EUG (0.1–0.5 mM) is due to the
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blocking of Ca2+ channels without, however, altering the activity of the contractile
intracellular machinery [85]. Similar results were also observed in canine myocytes,
where EUG reduced the amplitude and changed the kinetics of the Ca2+ current of
VDCC L-type channel [86].
Studies have also shown that endothelial TRP channels can participate in the
vasorelaxant effect of EUG (5 mg/kg, i.v). EUG at low concentrations (100 μM) is
able to activate TRPV4 currents in these cells, triggering actions that lead to
vasorelaxation [51].
It is known that among the predominant pathological changes in DM are blood
vessel alterations. Nangle et al. [87] demonstrated that the EUG (200 mg/kg/day,
p.o.) was able to reverse the increase in sensitivity to PHE and the reduction of
ACh-induced relaxation in the renal artery of diabetic rats. This mechanism
probably occurred through NO and EDHF.
As EUG has low toxicity, affects several vascular beds and has an inhibitory




In rat aorta, cinnamaldehyde has an endothelium-dependent relaxing effect on
contraction induced by KCl, prostaglandin F2 (PGF2), and NE [88]. Endothelium
dependence, however, has been refuted by Xue et al., since the vasorelaxant effect
induced by cinnamaldehyde was not mitigated by pretreatment with L-NAME
or ODQ [89]. In addition, these authors reported that COX, K+ channels, and
β-adrenergic receptors are not involved in the vasorelaxant effect of Cinnamaldehyde
[52, 88, 89].
In the coronary artery, cinnamaldehyde has a concentration-dependent and
endothelium-independent relaxing effect of maximum efficacy on contractions
induced by U46619 and KCl [90].
The cinnamaldehyde relaxation mechanism is suggested to occur due to alter-
ations of the sensitivity of contractile proteins to Ca2+ and, mainly, by inhibiting
VDCCs, as this monoterpenoid inhibited the contraction induced by BayK 8644 in
the coronary artery [52, 90]. Additionally, cinnamaldehyde has been shown to
reduce L-type Ca2+ currents in VSM cells (IC50 of 0.81  0.02 mM; maximum
efficacy) [52].
In the aorta and mesenteric artery of diabetic mice, cinnamaldehyde added to
the diet (% 0.02) improved the endothelial response to ACh without changing SBP.
Additionally, cinnamaldehyde prevented the production of ROS and depletion of
NO, with beneficial effect in DM [91, 92]. In DM, cinnamaldehyde (20 mg/kg/day)
also protected against the elevation of diastolic pressure, the increase in respon-
siveness to contracting agents and the hyporesponsiveness to ACh [93].
3.4.2 Citral
Citral is a monoterpenoid considered to be non-toxic and of therapeutic rele-
vance [54, 96]. Citral reversibly inhibited contractions induced by PHE (IC50
99.34 μg/mL) and KCl (IC50 110.80 μg/mL) in aorta of healthy rats with maximum
efficacy. The authors suggested that this effect occurs due to the blockade of
VDCCs, since citral inhibited contractions induced by BaCl2 and BayK 8644
[53, 54].
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Relaxing effect of citral was observed in the aortic artery of SHR. This
monoterpenoid in concentrations of 0.00624 mM–6.24 mM, induced a relaxing
effect partially dependent on the NO pathway. Additionally, citral blocked the
contraction induced by reposition of Ca2+ to nutrient solution, and this suggested
the hypothesis that this compound inhibits Ca2+ influx through VDCC channel [95].
3.4.3 Citronellal
Citronellal is a monoterpenoid composed of a racemic mixture of two enantio-
mers present in plants [96]. In normotensive animals, citronellal (10–40 mg/kg)
induced hypotension, bradycardia, and sinoatrial node block. The bradycardic
effect probably involves muscarinic receptors as it has been inhibited by atropine.
In hypertensive animals, citronellal (200 mg/kg) induced a hypotensive effect of
greater duration than that of NIF (1 h of NIF  3 h in citronellal) [55]. On contrac-
tions induced by PHE and KCl in the superior mesenteric artery of normotensive
rats, citronellal had a endothelium-independent and concentration-dependent
vasorelaxing effect, with maximum efficacy [55].
3.5 Ketone
3.5.1 Carvone
Carvone is a monocyclic monoterpenoid. Heuberger and collaborators [97]
investigated the effects of ()-carvone and (+)-carvone inhalation on the auto-
nomic nervous system. Inhalation of ()-carvone caused an increase in HR and
systolic blood pressure; (+)-carvone inhalation increased systolic and diastolic
blood pressure [97]. In rat aorta, carvone had a vasorelaxant effect (Emax = 58.9%)
for both enantiomers. The IC50 values for (+)-carvone in contractions induced by
PHE was 0.62 mM [57].
3.5.2 Rotundifolone
Rotundifolone (RT) is a monocyclic monoterpenoid. RT (1–30 mg/kg, i.v.) had a
hypotensive (partial efficacy = 51%) and bradycardic (partial efficacy = 87%) effect
in non-anesthetized rats. The hypotensive effect of RT was attenuated by atropine
and L-NAME, suggesting the participation of muscarinic receptors in this
effect [58].
On isolated aorta from rats, RT inhibited contractions induced by KCl (IC50
184 μg/ml (1.1 mM)) and PHE (IC50 185 μg/ml), with maximum efficacy. As a
mechanism of this effect, a possible blocking of VDCCs and of the release of Ca2+
from sarcoplasmatic reticulum by RT was suggested [58, 59]. Others also observed
the vasorelaxing effect of RT in the mesenteric artery of rats contracted with PHE
(pD2 = 4.0, maximum efficacy). As a mechanism for this effect, activity on TRPM8
channels, activation of large conductance Ca2+-activated K+ (BKCa) channels, and
inactivation of VDCCs were suggested [60, 98, 99].
3.5.3 1,8-cineol
1.8 cineole (CIN), also known as eucalyptol, in anesthetized and conscious
normotensive animals, CIN (0.3–10 mg/kg, i.v.) induced hypotension, with maxi-
mum effect in 20–30 s after administration and duration of 1–5 min. This effect was
independent of the autonomic nervous system, and a probable dependence on
vascular relaxation was suggested [62]. CIN (0.1 mg/kg, i.p.) has been shown to
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attenuate the elevation of systolic blood pressure in hypertensive rats induced by
chronic nicotine exposure [61].
In another study, in the aorta of normotensive rats, CIN inhibited PHE-induced
contraction (IC50 of 663.2 μg/ml (4.29 mM)). This effect was altered by the presence
of L-NAME but was not affected by indomethacin or tetrathylamonium [63].
3.5.4 Linalyl acetate
In hypertensive rats, the linalyl acetate (LA, 10–100 mg/kg, i.p.) attenuated the
increase in systolic and diastolic blood pressure. LA also modulates the expression of
Endothelial NO Synthase (eNOS), preventing its suppression by ROS. This
suggested a possible antihypertensive effect of LA [64, 65]. In rats with hyperten-
sion induced by chronic exposure to nicotine and stress, LA (10–100 mg/kg), had a
hypotensive effect [66].
It was reported that diabetic animals exposed to chronic stress showed a reduc-
tion in endothelial function, changes in SBP and HR. LA (100 mg/kg) was able to
revert these parameters to close to control values [100].
In a rabbit carotid artery, LA induced a relaxing effect on PHE-induced con-
traction, with partial efficacy (Emax = 88.8%) and IC50 3.6  10
4 M. According to
the authors, the cGMP-NO pathway and phosphorylation of myosin light chain, are
involved in the relaxing effect of this monoterpenoid, since it was attenuated by L-
NAME and ODQ [67]. It was also observed that the LA (300 μM) showed a relaxing
effect of PHE-induced contraction in the aorta of mice exposed to nicotine [101].
4. Final considerations
Based on these studies, it can be concluded that the vast majority of those
monoterpenes and monoterpenoids investigated and here presented have a hypo-
tensive and vasorelaxant effect. Concerning the hypotensive effect, the studies did
not include medium or long-term treatments; they were all about acute effects. In
terms of results obtained, there was great variation in the repercussion on heart rate:
concomitant tachycardia, in most cases, which was generally interpreted as a reflex
reaction to a hypotensive effect of primary vascular origin; bradycardia or no
change in heart rate in other cases. Concerning the investigation of the hypotensive
effect, in terms of the methodology of administration of monoterpene or
monoterpenoid, there was great variation in the route of administration employed,
intraperitoneal in some cases, intravenous and oral in others, which makes com-
parisons more difficult. Additionally, concerning the perspective of therapeutic use,
this is a relevant issue, since for long lasting treatment, as is the case with essential
hypertension, the oral route of administration is largely preferable, if not
mandatory.
Regarding the vasorelaxant effect, most studies describe a relaxing effect in rat
aortic rings on contractions mediated by EMC and PMC and suggested, as partici-
pant in mechanism of action, based on indirect evidence, the inhibitory effect of
these pharmacological agents on the activation of L type VDCC. Participation of K+
and TRP ionic channels, as well as intracellular mechanisms on monoterpene and
monoterpenoid-induced relaxation of contraction have been little investigated.
From the point of view of the possible therapeutic use of monoterpenes and
monoterpenoids for the treatment of arterial hypertension, it can be concluded that
several studies on the pressure and vascular effects have been carried out. These
studies point to a potential therapeutic use for several of these agents. However, in
general, they were restricted to the initial stages of a preclinical study.
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